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VALIDATION OF THE SPECTROPHOTOMETRIC METHOD  
OF DETERMINATION OF DRUG SUBSTANCE IN MEDICINE 
“CHLOROPYRAMINUM, CREAM” 
The article is devoted to validation of method of quantitative determination of drug substance – 
chloropyramine in medicine “Chloropiraminum, cream for external application, 10 mg/g”.  
The research purpose was to confirm documentarily that a spectrophotometric method is suitable 
for quantitative determination of chloropyramine hydrochloride in medicine “Chloropyraminum, cream 
for external application, 10 mg/g” and allows getting results with the required metrology characteristics. 
The research objects were the samples of medicine “Chloropyraminum, cream for external application, 
10 mg/g”. The absorbance measurements were conducted at the spectrophotometer of RV 2201A. 
It was developed the plan of validation, including the determination of the following validation 
characteristics: selectivity, trueness, application range, linearity and precision (repeatability and repro-
ducibility within the laboratory). For every validation characteristic the criteria of acceptability were 
calculated. In accordance with the developed plan the experimental researches were carried out and it 
was found out that validation characteristics were in the accordance with the criteria of acceptability. 
As a result of validation which was carried out in accordance with TKP 030-2013 (02040) it was con-
firmed that spectrophotometric method for determination of chloropyramine hydrochloride in medicine 
“Chloropyraminum, cream for external application, 10 mg/g” is available.  
Key words: validation, chloropyramine, cream, quantitative analysis, validation characteristics, 
criteria of acceptability. 
Introduction. “Chloropyramine” (suprastin) is 
one of the most widely used sedative antihista-
mines. It has a significant antihistamine activity, 
peripheral anticholinergic and antispasmodic effect 
moderate. It is effective in most cases, for the 
treatment of seasonal and perennial allergic rhino-
conjunctivitis, angioedema, urticaria, atopic der-
matitis, eczema, itching of various etiologies; in 
parenteral form for the treatment of acute allergic 
conditions, requiring emergency assistance. Me-
dicament produced in different dosage forms (tab-
lets, injections, ointments, creams) and has a plu-
rality of trade names (“Chloropyramine” “Supras-
tin”, “Allergozan”). 
The drug “Chloropyramine-cream” has a cream 
white color, smooth consistency, which is com-
posed of: Chloropyramine hydrochloride, polyeth-
ylene glycol 400, polyethylene glycol 4,000. 
The active ingredient is a drug Chloropyra-
mine hydrochloride (N-[(4-chlorophenyl)methyl]-N',  
N'-dimethyl-N-2-pyridinyl-ethane-1,2-diamine hyd-
rochloride) of white or almost white, crystalline 
powder with low odor, readily soluble in water and 
chloroform, soluble in 96% alcohol. 
Quantitative determination Chloropyramine 
hydrochloride can be carried out by two methods: 
spectrophotometric method and the non-aqueous 
titration with perchloric acid. 
Nonaqueous titration method is based on the 
reaction of Chloropyramine hydrochloride mercury 
acetate (II), formed with Chloropyramine acetate 
solutionwichis titrated with 0.1M perchloric acid 
until green dye (indicator – 0.1% crystal violet so-
lution). 
The main disadvantages of the method are the 
use of a non-aqueous titration, the titration setup 
sealed and toxic volatile solvent. 
Spectrophotometric method for determining 
the solutions is based on the ability to absorb ultra-
violet radiation Chloropyramine hydrochloride, 
with a maximum absorptionwichis observed at  
a wavelength (λmax), equal to 244 nm. 
To confirm the suitability of analytical meth-
ods are provided for the validation procedure 
which includes the following stages: design valida-
tion plan, experimental studies, statistical pro-
cessing of the results and the formulation of  
the validation report. 
The purpose of this work is to document the 
data validation that the spectrophotometric method 
is suitable for the quantitative determination of 
Chloropyramine hydrochloride drug “Chloropyra-
mine, cream for external use 10 mg/g” and allows  
to obtain results with the required metrological 
characteristics. 
Main part. Object of research is to investigate 
some prototypes of PM Chloropyramine in the 
form of cream for external use 10 mg/g. The com-
ponents of the cream is LS base: polyethylene gly-
col 400; polyethylene glycol 4,000. 
To carry out the test solution of 1.000 g of drug 
was dissolved in 50.0 ml of 96% alcohol. Then 
itwas adjusted to 100.0 ml of 96% alcohol and 
stirred. 
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Chloropyramine hydrochloride of 0.050 g was 
taken as the standard sample solution (SB). Then it 
was dissolved in 50.0 ml of 96% alcohol; 1.0 ml of 
the resulting solution was adjusted to 100.0 ml of 
96% alcohol and stirredwith the solution: 96% 
ethyl alcohol, optical density measurements was 
carried out with a spectrophotometer PB 2201A. 
Measurement conditions: wavelength 244 nm; cell 
with 10 mm layer thickness. The results of meas-
urements of the optical densities of the test solution 
and a solution of the hydrochloride salt of SB 
Chloropyramine were calculated depending on 
considering concentration of Chloropyramine PM 
hydrochloride. 
Results and discussion. It was selected as a 
validation characteristics: selectivity, accuracy, 
application range, linearity and precision (repeata-
bility and within-laboratory reproducibility). 
Validation criteria in the table below was es-
tablishedin accordance with the recommendations 
of [1/2] for each validation characteristics. 
Selectivity is determined by comparing the op-
tical “placebo” mud density and drug solution with 
analytical wavelengthof 244 nm. The eligibility 
criteria is the components of “placebo” should not 
affect the determination of Chloropyramine hydro-
chloride PM. 
An analysis was performed on five concentration 
levels: 0.007, 0.008, 0.010, 0.012, 0.013 mg/ml, 
which corresponds to 70, 80, 100, 120 and 130% of 
the nominal content Chloropyramine hydrochloride 
PM respectively to determine the linearity of the 
method of application within range (70–130% of 
the nominal content Chloropyramine hydrochlo-
ride). The following equation was used according 
to the linear dependenceusing the normalized co-
ordinate by the least squares: 
( )/ 100 / 100 ,i st i stA A b C C a⋅ = ⋅ +  
where Ai is optical density; Ast is optical density of 
100% for the given values of the argument; Ci is 
concentration, Cst is the concentration of 100%. 
In accordance with the recommendations given 
in [2], in addition to the requirements for the corre-
lation coefficient and residual standard deviation 
(RSD0) it was calculated eligibility criteria for free 
as a member, for spectrophotometry necessarily 
determine whether a straight line passes through 
the origin. 
Repeatability was assessed by the results of  
6 parallel tests carried out on a series of drugs in a 
single day in the same conditions. The eligibility 
criteria is the relative standard deviation (RSD, %) 
for the definitions and it should not exceed 2.0%. 
Within-laboratory reproducibility was assessed 
by the results of 6 parallel tests a series of drugs, 
carried out by two analysts on different days. As 
the results of testsit was performed by one of ana-
lysts using the results obtained by determining the 
frequency of occurrence. The test results were 
checked for homogeneity by Q-sample test. In or-
der to detect statistically significant differences 
between the variances and the arithmetic mean of 
the results of the two series, produced under differ-
ent conditions, using the criteria of Fisher and Stu-
dent. Eligibility criteria are the calculated values of 
Fisher's exact test and Student's test shall not ex-
ceed the tabulated values for the 95% confidence 
level and a predetermined number of measure-
ments; relative standard deviation of the results 
(RSD, %), calculated for the quantitative content 
Chloropyramine hydrochloride obtained in terms 
of repeatability They must not exceed 2.0%.  
Determining the accuracy of the procedure was 
verified by quantitative testing of model solutions 
prepared with a known amount Chloropyramine 
hydrochloride three concentrations within the 
range of application methods: 8.0; 10.0; 12.0 mg/g 
(80; 100; 120% of the nominal content Chloropy-
ramine hydrochloride) using 6 plays for each con-
centration. Validation of the data was carried out 
by calculating the offset │ x −μ │test the signifi-
cance of differences between the random variable 
x  from the constant μ and the mean degree of re-
duction of the eligibility criteria ( ).Z The percent-
age of the recovery obtained in the analysis of so-
lutions with an active substance content of 80,  
100 and 120%, adjusted 100%, should be in the 
range of 95.0 to 105.0%. The displacement of the 
measurement resultis divided by the standard devi-
ation to the absolute average value shall not exceed 
the value of t-test for a confidence probability  
P = 95% and the specified number of dimensions. 
In determining the specificity technique has 
been found that placebo solution components have 
no absorption at a wavelength of 244 nm and a 
method of determining the quantitative content in 
Chloropyramine selective PM defined with respect 
to the component. 
Statistical processing of the linear dependence 
of the values obtained from the hydrochloride con-
tent Chloropyramine specified content correlation 
coefficient of linear regression graph was 0.999 
and the value of the free term – 1.63, the residual 
standard deviation is 0.0015. Thus, the method is 
linear in the range 70–130%, which corresponds to 
concentrations of working solutions of 0,007–
0.013 mg/ml of Chloropyramine. 
It was establishedthe convergence (repeatability) 
method tests of the quantitative determination of Chlo-
ropyramine hydrochloride. The relative standard devia-
tion of the mean (RSD, %) was calculated for the con-
tent of Chloropyramine hydrochloride obtained in PM.  
94 Validation of the spectrophotometric method of determination of drug substance in medicine  
Proceedings of BSTU   No. 4   2016 
Validation results (range D – 70–120%, the content of tolerance B = ±5%, n = 6) 
Validationcriteria Resultingvalue Criticalvalue 
Specificity 
The components of “placebo” should not distort the result  
Corresponded  – 
Linearity: y = bx + a   
Residualstandarddeviation 0
(0.95; 2)
0.32 ,%
n
b BRSD
t −
⋅ ⋅≤  0.0015 max RSD0 = 0.497 
Freemember (0.95; 2)a n aa t RSD−≤ Δ = ⋅  1.63 max a = 3.17 
Correlation coefficient (0.95; 2)
0.32 /
1 n
y
b B t
r
RSD
−⋅ ⋅≥ −  0.999 min r = 0.99 
Accurateness 
Percentage of recovery Z , % 
Student's criterion  
 
97.99Z =  
t0 = 1.75 
 
95 105Z = −  
t(0.95;5) = 2.57 
Frequency 
Coefficient of variation RSD, % 
 
0.23 
 
max 2RSD =  
Intermediate precision 
Coefficient of variation RSD, % 
Student's criterion t0 ≤ t(0.95;f) 
Fisher's criterion 
1 20 (0.95; ; )f f
F F≤  
 
0.30 
0.13 
1.71 
 
max 2%RSD =  
t(0.95;10) = 2.23 
F(0.95;5;5) = 5.05 
 
The repeatable conditions is 0.23%, which meets 
the criterion of acceptability: not more than 2.0%. 
It was confirmed within reproducibility of the 
method: the calculated values of the Fisher crite-
ria and Student does not exceed the limit values; 
the relative standard deviation of the mean (RSD, %) 
results for the quantitative determination Chloro-
pyramine hydrochloride is 0.3% in PM, which 
corresponds to the acceptability criteria: not more 
than 2.0%. 
The accuracy of the procedure is confirmed by 
the relevant tests on simulated samples for the 
three concentrations within the range of application 
of testing methods, with 6 repetitions. The results 
determine the lack of emissions (homogeneous 
sample). The average percentage of recovery was
97.99%, which corresponds to the eligibility crite-
ria established 95.0–105.0%. The offset measure-
ment result was divided by the standard deviation 
to the absolute average value. It does not exceed 
the value of Student's t test for P = 95% and the 
specified number of dimensions. 
Determination results of performance charac-
teristics and validation accuracy quantification 
techniques Chloropyramine hydrochloride are pre-
sented in the table. 
Conclusion. Validation results are confirmed 
with the suitability of the use of spectrophotomet-
ric method for the quantitative determination of 
Chloropyramine hydrochloride as sucndrug as 
“Chloropyramine, in the form of cream for external 
use 10 mg/g”. 
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